Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201102071 Principal Investigator: Linette, Gerald
Title: A phase 0, exploratory study of the pharmacodynamics of a single intratumoral dose of IMCgp100, a monoclonal T cell receptor anti-CD3 scFv fusion protein, in subjects with advanced unresectable melanoma
Phase: 0 Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
In this study, we will test the effect of the drug IMCgp100 directly on tumors by injecting the drug directly into the tumor.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)